Skip to main content

Table 2 Clinical characteristics of ABE-positive cohorts and ABE-negative cohorts

From: The differential value of radiomics based on traditional T1-weighted sequences in newborns with hyperbilirubinemia

  

Cohorts

  

Information

 

ABE-positive

ABE-negative

P

Gestational Age (weeks)

Range

35.00-41.43

35.14–41.86

0.22

Mean ± STD

38.28 ± 1.46

38.69 ± 1.54

Birth weight (g)

Range

2200.00-5050.00

2250.00-4350.00

0.16

Mean ± STD

3131.63 ± 499.60

3284.08 ± 509.80

Gender

Male

25

19

1.0

Female

25

19

Age at MRI (weeks)

Range

0.29–3.57

0.43–3.14

0.35

Mean ± STD

1.31 ± 0.73

1.17 ± 0.63

Corrected Age (weeks)

Range

36.00-43.14

35.86–42.43

0.64

Mean ± STD

39.64 ± 1.62

39.79 ± 1.37

Mode of Delivery

Eutocia

28

30

0.024*

Cesarean

22

8

Age at admission (hours)

Range

26–518

26–456

0.14

Median

160.50

125

Peak of TSB (µmol/L)

Range

302.00-690.60

256.60-606.30

0.46

Mean ± STD

455.41 ± 91.94

441.14 ± 84.43

B/A (mg/dl: g/l)

Range

4.50–11.50

4.80–10.50

0.95

Mean ± STD

7.41 ± 1.54

7.38 ± 1.31

Length of Stay (days)

Range

4–31

3–12

0.034*

(U = 701)

Median

7

5.50

Treatment

Phototherapy

4

4

0.72

Phototherapy +Exchange Transfusion

46

34

  1. Note: Corrected Age = Gestational Age (weeks) + Age at MRI (weeks), TSB = total serum bilirubin, B/A = bilirubin/albumin